Cargando…
Clinical significance of hypertension in patients with different types of cancer treated with antiangiogenic drugs
Hypertension is a common comorbidity in patients receiving antiangiogenic therapy. Prior studies have reported worsening or new-onset hypertension as an adverse event of antiangiogenetic therapy, which can be managed by dose reduction or discontinuation of the culprit medication. By contrast, other...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933774/ https://www.ncbi.nlm.nih.gov/pubmed/33692847 http://dx.doi.org/10.3892/ol.2021.12576 |